EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
2 Growth Stocks Set to Flourishand 1 We Question
New Novavax R&D Leader Raises Questions On Valuation Gap And Outlook
Novavax (NASDAQ:NVAX) Stock Price Passes Above 200 Day Moving Average - Here's Why
Shah Capital Management Purchases 2,747,000 Shares of Novavax, Inc. $NVAX - Daily Political
3 Companies Built Their Fortunes on COVID Vaccines, but Only 1 Has a Real Plan for What Comes Next
A Look Back at Biotechnology Stocks' Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
Evaluating Novavax (NVAX) Valuation As Licensing Deal And Recent Returns Shape Market Expectations
3 Stocks Under $50 That Concern Us
Novavax, Inc. (NASDAQ:NVAX) Receives $11.88 Average Target Price from Analysts - Markets Daily
Unpacking Q4 Earnings: Halozyme Therapeutics (NASDAQ:HALO) In The Context Of Other Therapeutics Stocks
Q3 Earnings Forecast for Novavax Issued By Zacks Research
Therapeutics Stocks Q4 In Review: United Therapeutics (NASDAQ:UTHR) Vs Peers
2 Healthcare Stocks to Target This Week and 1 That Underwhelm
Q3 Earnings Estimate for Novavax Issued By Zacks Research
Assessing Novavax (NVAX) Valuation As Licensing Income And COVID Momentum Shape Expectations
6 years since lockdown, here's a look at COVID vaccine guidance today - Yahoo News Canada
Q4 Earnings Highlights: BioMarin Pharmaceutical (NASDAQ:BMRN) Vs The Rest Of The Therapeutics Stocks
Therapeutics Stocks Q4 Teardown: Moderna (NASDAQ:MRNA) Vs The Rest
Assessing Novavax (NVAX) Valuation After Recent Share Price Volatility And Vaccine Partnership Momentum
3 Profitable Stocks That Concern Us
Novavax, Inc. (NASDAQ:NVAX) Given Average Rating of "Hold" by Brokerages
Q4 Earnings Outperformers: Vertex Pharmaceuticals (NASDAQ:VRTX) And The Rest Of The Therapeutics Stocks
Novavax (NASDAQ:NVAX) Trading 7.6% Higher - Should You Buy?
Nuvaxovid (Novavax) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
Assessing Novavax (NVAX) Valuation After Strong 2025 Results And Return To Profitability
Novavax (NASDAQ:NVAX) Share Price Passes Above Two Hundred Day Moving Average - Here's What Happened
Q4 Earnings Highs And Lows: Amgen (NASDAQ:AMGN) Vs The Rest Of The Therapeutics Stocks
How Investors Are Reacting To Novavax (NVAX) Swinging From Losses To Profits On Vaccine Revenue
Assessing Novavax (NVAX) Valuation After Strong Earnings Beat And Return To Profitability
Novavax Inc (NVAX) - Insider Monkey
Novavax, Inc. $NVAX Stock Position Lowered by Vanguard Group Inc. - Daily Political
Novavax News
Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact
Meta Platforms: Navigating Legal Headwinds and AI Opportunities for Investors
US Stocks Poised for Potential Rebound Amidst Easing Geopolitical Tensions and Shifting Investor Positioning
UAE as Global Gold Powerhouse: Analyzing the 2026 Resilience of Dubai’s Gold Trading Ecosystem
Investing in US Stocks from South Africa: Step-by-Step Guide for ZA Investors
How to Invest in Stocks for Beginners (Europe): Opportunities, Risks and Smart Strategies in 2026
Forex Market Today: BRICS+ Currency Dynamics, USD/AED Stability, Key Currency Trading Opportunities
Latest news
Show moreUkraine Forges New Alliances in the Middle East, Leveraging Defense Expertise
Fed Policy Pivot: Inflation Risks Hint at Potential Rate Hikes, Shifting Market Expectations
TotalEnergies Dominates Middle East Oil Market in March, Securing Record Profits
Navigating Economic Crosscurrents: Market Outlook Amidst Geopolitical Turmoil
Ukraine Hints at Reduced Strikes on Russian Energy Amid Partner Pressure, Secures Middle East Support
